Rx Medicare

Practice Fusion Inc., the free, web-based electronic health record (EHR) for physicians, today implemented a first-of-its-kind tool that allows its physician-users to immediately and accurately identify all Tier 1 candidates for H1N1 vaccination from their patient populations using criteria published by the Centers for Disease Control and Prevention (CDC).

Read More…

Related Posts

• Groups At High Risk Of H1N1 Influenza A Should Avoid Travelling To 2009 HAJJ
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Baxter Receives EMEA Positive Opinion For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Doctors, Health Care Workers On H1N1 Vaccine Priority List; Front-Line Caregivers Planning Now To Keep Patients Safe
• Drug Resistant Influenza A Virus Potentially Serious To High-Risk Patients
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• High Dose Seasonal Influenza Vaccine Specifically Intended For People Ages 65 And Older Approved By U.S. FDA
• Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
• H1N1 Health Alert: Children With Asthma At Greater Risk From H1N1 Influenza
• As Influenza Cases Rise In Europe, Experts Urge Uptake Of H1N1 Vaccine
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• Potential Allergen In H1N1 Swine Flu Vaccine May Put Children At Risk-Only Phadia Reveals Both Presence And Severity Of The Allergy
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• Health Canada Approves Pandemic H1N1 Flu Vaccine For Canadians

Tags: 300000, efficacy, fusion, guidelines, h1n1, high, identifies, influenza, line, pandemic, patients, practice, risk, vaccine

This entry was posted on Sunday, October 25th, 2009 at 12:10 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.